Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3024% above fair value
$31.88−0.53 (-1.64%)
Close on Nov 18, 2026Market cap $1.37BP/E 39.4Yield 1.19%
Cadre operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cadre's operating income for the twelve months ending Jun 30, 2026 was $69.07M, up 9.5% year over year. For fiscal 2025 it was $67.35M, up 0.9% from the year before. The highest annual figure on record is $67.35M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.35M | +0.9% |
| FY2024 | Dec 31, 2024 | $66.76M | +18.1% |
| FY2023 | Dec 31, 2023 | $56.52M | +238.1% |
| FY2022 | Dec 31, 2022 | $16.72M | -67.7% |
| FY2021 | Dec 31, 2021 | $51.72M | +3.8% |
| FY2020 | Dec 31, 2020 | $49.80M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.46M | +53.0% |
| Q1 FY2026 | Mar 31, 2026 | $7.49M | -44.7% |
| Q4 FY2025 | Dec 31, 2025 | $20.44M | -30.5% |
| Q3 FY2025 | Sep 30, 2025 | $18.67M | +244.2% |
| Q2 FY2025 | Jun 30, 2025 | $14.69M | -26.4% |
| Q1 FY2025 | Mar 31, 2025 | $13.55M | +13.1% |
| Q4 FY2024 | Dec 31, 2024 | $29.40M | +131.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.43M | -67.6% |
| Q2 FY2024 | Jun 30, 2024 | $19.95M | +25.6% |
| Q1 FY2024 | Mar 31, 2024 | $11.98M | +6.8% |
| Q4 FY2023 | Dec 31, 2023 | $12.68M | -0.4% |
| Q3 FY2023 | Sep 30, 2023 | $16.73M | +62.2% |
| Q2 FY2023 | Jun 30, 2023 | $15.89M | +94.8% |
| Q1 FY2023 | Mar 31, 2023 | $11.22M | – |
| Q4 FY2022 | Dec 31, 2022 | $12.72M | +36.5% |
| Q3 FY2022 | Sep 30, 2022 | $10.32M | -10.6% |
| Q2 FY2022 | Jun 30, 2022 | $8.16M | -47.1% |
| Q1 FY2022 | Mar 31, 2022 | -$14.48M | -193.8% |
| Q4 FY2021 | Dec 31, 2021 | $9.32M | +0.3% |
| Q3 FY2021 | Sep 30, 2021 | $11.54M | -9.5% |
| Q2 FY2021 | Jun 30, 2021 | $15.42M | – |
| Q1 FY2021 | Mar 31, 2021 | $15.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $9.29M | – |
| Q3 FY2020 | Sep 30, 2020 | $12.76M | – |
See a number that looks wrong?